New Orleans - Topical imiquimod (Aldara) treatment may play a role in preventing UVB-induced cutaneous immunosuppression, Anthony A. Gaspari, M.D., said at the annual meeting of the American Academy of Dermatology.
Discovering Dermatology Times: March 2024 Enhancing Psoriasis Management Supplement
ReV Up Your Vitiligo Treatment Strategies
Skin Swab Analysis Reveals Early Predictors of Atopic Dermatitis in Infants
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Reviewing Late-Breaking Research From AAD 2024
A Spotlight on SCIN: A New Tool From Google and Researchers at Stanford Medicine